This $8.9 Million Buy Targets a Stock Down 68% With $322 Million in Cash

DAFNA Capital Management purchased 720,000 shares of Biohaven in Q4, an estimated trade size of $8.92 million based on Q4 2025 average prices. The report is a factual filing of institutional accumulation and signals modest positioning interest but is unlikely by itself to move the stock materially. Monitor for follow-up filings or additional buys to assess whether this is a sustained allocation change.

Analysis

DAFNA Capital Management purchased 720,000 shares of Biohaven in Q4, an estimated trade size of $8.92 million based on Q4 2025 average prices. The report is a factual filing of institutional accumulation and signals modest positioning interest but is unlikely by itself to move the stock materially. Monitor for follow-up filings or additional buys to assess whether this is a sustained allocation change.